The multiple isoforms of the transmembrane glycoprotein CD44 are produced by alternative RNA splicing. Expression of CD44 isoforms containing variable 5 exon (v5) correlates with enhanced malignancy and invasiveness of some tumors. Here we demonstrate that SRm160, a splicing coactivator, regulates CD44 alternative splicing in a Ras-dependent manner. Overexpression of SRm160 stimulates inclusion of CD44 v5 when Ras is activated. Conversely, small interfering RNA (siRNA)-mediated silencing of SRm160 significantly reduces v5 inclusion. Immunoprecipitation shows association of SRm160 with Sam68, a protein that also stimulates v5 inclusion in a Ras-dependent manner, suggesting that these two proteins interact to regulate CD44 splicing. Importantly, siRNA-mediated depletion of CD44 v5 decreases tumor cell invasion. Reduction of SRm160 by siRNA transfection downregulates the endogenous levels of CD44 isoforms, including v5, and correlates with a decrease in tumor cell invasiveness.CD44 is a transmembrane glycoprotein that mediates the response of cells to their cellular microenvironment. CD44 is expressed in most tissues, where its gene products function in lymphocyte homing, adhesion, migration, and regulation of cell growth (for review, see reference 35). This variety of roles results from multiple CD44 isoforms produced by alternative splicing (3). The CD44 gene is composed of 10 constitutively spliced exons and 10 variable exons, residing between constitutive exons 5 and 6.Interestingly, the peptides encoded by these variable exons are located in the extracellular domain of the protein. Some of these alternative spliced variants interact with growth factors and render cells responsive to extracellular stimuli (2,17,33,(37)(38)(39)43). The CD44 splice variant containing variable exon 6 (v6) can form a complex with the extracellular hepatocyte growth factor (HGF) and its tyrosine kinase receptor Met (33). Formation of this CD44 v6-HGF-Met complex stimulates the activation of Met through autophosphorylation and further activates Met-dependent Ras signaling, probably through the association of ERM (ezrin-radixin-moesin) proteins to the cytoplasmic tail of CD44 (33). The net result is that the CD44 v6-HGF-Met complex activates Ras signaling and promotes cell proliferation. Interestingly, Ras activation also stimulates transcription of CD44 and promotes inclusion of its variable exons (14,19). This constitutes a CD44-mediated positive feedback loop in the activation of Ras signaling if a factor such as HGF is present. Alternatively, the tumor suppressor protein merlin can also bind to the cytoplasmic tail of CD44. Binding of merlin to CD44 disrupts the interaction between ERM and CD44 and therefore inhibits Ras activation (29). As a result, Ras-dependent CD44 alternative splicing is inhibited, the positive feedback loop is disrupted, and cell growth diminishes. Consistent with the above observations, the majority of CD44 expressed in resting lymphocytes is in the constitutively spliced form (standard form), whereas the v...